These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 82583)
41. T lymphocyte-dependent B lymphocyte proliferative response to antigen. II. Induction of polyclonal B lymphocyte activation of normal B cells and of Lyb-5- B cells from xid mice via recognition of self-IA antigens. Tse HY; Kanamori S; Mond JJ J Immunol; 1984 Oct; 133(4):1792-800. PubMed ID: 6206138 [TBL] [Abstract][Full Text] [Related]
42. The ontogeny of murine B lymphocytes. I. Induction of phenotypic conversion of Ia-to Ia+ lymphocytes. Hammerling U; Chin AF; Abbott J; Scheid MP J Immunol; 1975 Nov; 115(5):1425-31. PubMed ID: 170344 [TBL] [Abstract][Full Text] [Related]
43. The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect. Mosier DE; Mond JJ; Goldings EA J Immunol; 1977 Dec; 119(6):1874-8. PubMed ID: 334975 [TBL] [Abstract][Full Text] [Related]
44. Polyclonal B-cell activation by a B-cell differentiation factor B151-TRF2. IV. B151-TRF2-responsive F1 B cells consist of two separate populations capable of recognizing only one of the parental I-A products expressed on B cells. Takaháma Y; Ono S; Glimcher LH; Hamaoka T J Mol Cell Immunol; 1987; 3(3):177-94. PubMed ID: 3509923 [TBL] [Abstract][Full Text] [Related]
45. Influenza viruses as lymphocyte mitogens. I. B cell mitogenesis by influenza A viruses of the H2 and H6 subtypes is controlled by the I-E/C subregion of the major histocompatibility complex. Scalzo AA; Anders EM J Immunol; 1985 Feb; 134(2):757-60. PubMed ID: 3155540 [TBL] [Abstract][Full Text] [Related]
46. Selective effects of anti-Ia serum and complement treatment upon polyclonal B lymphocyte responses to dextran sulfate and lipopolysaccharide. Bick PH; Shreffler DC J Immunol; 1979 Nov; 123(5):2298-303. PubMed ID: 90706 [TBL] [Abstract][Full Text] [Related]
47. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells. Callahan GN J Immunol; 1984 May; 132(5):2649-57. PubMed ID: 6201554 [TBL] [Abstract][Full Text] [Related]
48. IA mutant functional antigen-presenting cell lines. Glimcher LH; Hamano T; Asofsky R; Sachs DH; Pierres M; Samelson LE; Sharrow SO; Paul WE J Immunol; 1983 May; 130(5):2287-94. PubMed ID: 6300242 [TBL] [Abstract][Full Text] [Related]
49. Newborn and Wiskott-Aldrich patient B cells can be activated by TNP-Brucella abortus: evidence that TNP-Brucella abortus behaves as a T-independent type 1 antigen in humans. Golding B; Muchmore AV; Blaese RM J Immunol; 1984 Dec; 133(6):2966-71. PubMed ID: 6436369 [TBL] [Abstract][Full Text] [Related]
50. Polyclonal activation of the murine immune system by an antibody to IgD. IV. In vivo activation of B lymphocytes from immune defective CBA/N mice. Muul LM; Scher I; Mond JJ; Finkelman FD J Immunol; 1983 Nov; 131(5):2226-31. PubMed ID: 6605378 [TBL] [Abstract][Full Text] [Related]
51. Generation of T helper cells in vitro. III. Helper cell culture-derived factors are related to alloantigens coded for the I region of the H-2 major histocompatibility complex. McDougal JS; Cort SP; Gordon DS J Immunol; 1977 Dec; 119(6):1933-7. PubMed ID: 303255 [TBL] [Abstract][Full Text] [Related]
52. Frequency analysis of functional immunoglobulin C and V gene expression in murine B cells at various ages. Hooijkaas H; Preesman AA; Van Oudenaren A; Benner R; Haaijman JJ J Immunol; 1983 Oct; 131(4):1629-34. PubMed ID: 6604747 [TBL] [Abstract][Full Text] [Related]
53. Establishment of an antigen-specific B cell clone by somatic hybridization. Hamano T; Murata Y; Yamasaki T; Yasuda Y; Iwasaki T; Nagai K J Immunol; 1987 Oct; 139(8):2556-61. PubMed ID: 2821118 [TBL] [Abstract][Full Text] [Related]
54. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways. Singer A; Kruisbeek AM; Andrysiak PM J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534 [TBL] [Abstract][Full Text] [Related]
55. In vivo treatment with monoclonal anti-I-A antibodies: disappearance of splenic antigen-presenting cell function concomitant with modulation of splenic cell surface I-A and I-E antigens. Kruisbeek AM; Titus JA; Stephany DA; Gause BL; Longo DL J Immunol; 1985 Jun; 134(6):3605-14. PubMed ID: 2580891 [TBL] [Abstract][Full Text] [Related]
56. Induction of B cell priming by neonatal injection of mice with thymic-independent (type 2) antigens. Mosier DE J Immunol; 1978 Oct; 121(4):1453-9. PubMed ID: 359707 [TBL] [Abstract][Full Text] [Related]
57. Cross-priming of murine B cells with TNP conjugates of hemocyanin and Ficoll: characteristics of primed B cells responding to both antigens. Umetsu DT; Chapman-Alexander JM; Thorbecke GJ J Immunol; 1979 Jul; 123(1):396-404. PubMed ID: 312880 [No Abstract] [Full Text] [Related]
59. Cellular and genetic control of antibody responses in vitro. IV. Expression of Ia antigens on accessory cells required for responses to soluble antigens including a response under Ir gene control. Hodes RJ; Ahmann GB; Hathcock KS; Dickler HB; Singer A J Immunol; 1978 Oct; 121(4):1501-9. PubMed ID: 81238 [No Abstract] [Full Text] [Related]
60. Expression of Ia antigens on hapten-specific B cells. I. Delineation of B-cell subpopulations. Press JL; Klinman NR; McDevitt HO J Exp Med; 1976 Aug; 144(2):414-27. PubMed ID: 1085328 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]